Individual responses to treatment may vary, and outcomes cannot be guaranteed
Due to recent advancements and accessibility to gene testing, it is now understood that the patient has GTSM 1 and MTHFR polymorphisms contributing to his condition
Moreover, using probucol (500 mg/day, P.O for 6 months) for secondary prevention in patients with CHD lowered the incidence of the patients primary endpoint (cardiovascular disease death, hospitalization rate), which may be partly due to its strong antioxidant capacity [245]
Medically reviewed by Faisal Shafiq (Superintendent Pharmacist, GPhC registration number 2067224)
This selective effect is crucial as it suggests that 5-amino-1MQ might target cancer cells more specifically without broadly affecting other cells [10]
They review your medical history, current medications, and what you are hoping to address